Mallinckrodt ARD LLC
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy (NCT03400852) | Mallinckrodt ARD LLC | 2018-07-27 |
Track Mallinckrodt ARD LLC automatically
Every clearance here is in the API, with alerts when new ones post.